DEUTSCHE BANK AG\ - MIRAGEN THERAPEUTICS INC ownership

MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 31 filers reported holding MIRAGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of MIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$10,000
-64.3%
21,353
-46.0%
0.00%
Q3 2019$28,000
-91.1%
39,544
-74.2%
0.00%
Q2 2019$313,000
-36.6%
153,076
-13.7%
0.00%
Q1 2019$494,000
-14.4%
177,442
-6.9%
0.00%
Q4 2018$577,000
-6.5%
190,653
+72.0%
0.00%
Q3 2018$617,000
+7.1%
110,849
+23.4%
0.00%
Q2 2018$576,000
+51.6%
89,862
+65.5%
0.00%
Q1 2018$380,000
-40.1%
54,293
-10.9%
0.00%
Q4 2017$634,000
+521.6%
60,917
+437.4%
0.00%
Q3 2017$102,000
-44.9%
11,336
-21.7%
0.00%
Q2 2017$185,00014,4790.00%
Other shareholders
MIRAGEN THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
CVI Holdings, LLC 92,200$646,0000.88%
683 Capital Management, LLC 500,000$3,505,0000.31%
BIEGEL & WALLER LLC 66,508$466,0000.30%
Monashee Investment Management LLC 94,000$659,0000.18%
Aveo Capital Partners, LLC 16,732$117,0000.05%
Artal Group S.A. 500,000$3,505,0000.04%
Radnor Capital Management, LLC 10,000$70,0000.02%
Tower Research Capital LLC (TRC) 12,672$89,0000.01%
Trexquant Investment LP 15,757$110,0000.01%
FMR LLC 4,332,888$30,374,0000.00%
View complete list of MIRAGEN THERAPEUTICS INC shareholders